ACTIVE

GSK-Beheer

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

104,2 k €

+27781.8% YoY

Gross margin

155,3 k €

+179.4% YoY

Equity

514,2 k €

+3.9% YoY

What does GSK-Beheer do?

GSK-Beheer is a Private limited company incorporated in 2005. Its registered office is in Hasselt.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0871.717.917

Incorporation

07/02/2005

Legal form

Private limited company

Registered office

Guffenslaan 44
3500 Hasselt · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2010		2008		2007		2006
Income statement
Gross margin	155,3 k €	+179%	55,6 k €	+42.5%	39 k €	-60.3%	98,1 k €	+18.9%	82,6 k €	-21.2%	104,7 k €	+13.4%	92,3 k €	+114%	43,1 k €	-18.0%	52,6 k €	-65.1%	150,5 k €	+263%	41,5 k €	+366%	8,9 k €	-95.9%	215,4 k €	+1555%	13 k €	-75.5%	53,1 k €	+909%	-6,6 k €	-101%	792,6 k €	-17.9%	965,5 k €	+194%	328,8 k €	+29.5%	254 k €
EBITDA	125,3 k €	+384%	25,9 k €	+189%	9 k €	-87.1%	69,4 k €	+20.9%	57,4 k €	-31.2%	83,3 k €	+29.4%	64,4 k €	+227%	19,7 k €	-34.6%	30,1 k €	-75.8%	124,4 k €	+663%	16,3 k €	+248%	-11,1 k €	-106%	192,1 k €	+2191%	-9,2 k €	-166%	14 k €	+157%	-24,5 k €	-103%	734,1 k €	-20.9%	928,1 k €	+211%	298,6 k €	+30.0%	229,7 k €
Operating result	95,5 k €	+13953%	679,8 €	+104%	-16,5 k €	-136%	46,4 k €	+34.8%	34,4 k €	-41.2%	58,6 k €	+77.8%	32,9 k €	+199%	-33,3 k €	-45.6%	-22,8 k €	-132%	72,3 k €	+320%	-32,8 k €	+39.2%	-54 k €	-141%	131,8 k €	+364%	-49,9 k €	-121%	-22,5 k €	+46.9%	-42,4 k €	-106%	677,9 k €	-21.3%	860,8 k €	+231%	260,4 k €	+35.7%	191,9 k €
Net result	104,2 k €	+27782%	-376,4 €	+97.3%	-13,9 k €	+61.9%	-36,6 k €	-226%	29 k €	-10.1%	32,2 k €	+0.8%	31,9 k €	+231%	9,7 k €	-32.5%	14,3 k €	-88.5%	124,6 k €	+199%	41,6 k €	+12.4%	37,1 k €	-79.0%	176,4 k €	+9534%	1,8 k €	-97.4%	69,7 k €	+278%	18,5 k €	-99.0%	1,9 M €	+167%	694,4 k €	+226%	212,7 k €	+21.1%	175,6 k €
Balance sheet
Equity	514,2 k €	+3.9%	495 k €	-33.6%	745,4 k €	-1.8%	759,3 k €	-4.6%	795,9 k €	-0.1%	796,9 k €	-0.3%	799,7 k €	-72.7%	2,9 M €	-10.4%	3,3 M €	+0.4%	3,3 M €	+4.0%	3,1 M €	+1.3%	3,1 M €	+1.2%	3,1 M €	+4.5%	2,9 M €	+0.1%	2,9 M €	+2.4%	2,8 M €	+0.7%	2,8 M €	+126%	1,3 M €	+109%	598,2 k €	+55.2%	385,5 k €
Total assets	1,5 M €	+4.4%	1,4 M €	-3.3%	1,5 M €	-5.1%	1,5 M €	-8.8%	1,7 M €	+1.3%	1,7 M €	-56.5%	3,8 M €	-8.9%	4,2 M €	-1.1%	4,3 M €	-1.2%	4,3 M €	+2.4%	4,2 M €	-1.9%	4,3 M €	-4.8%	4,5 M €	+7.8%	4,2 M €	+11.1%	3,8 M €	+3.5%	3,6 M €	+6.0%	3,4 M €	+64.8%	2,1 M €	+64.6%	1,3 M €	+23.5%	1 M €
Cash	30,6 k €	-27.8%	42,3 k €	-75.9%	175,6 k €	-17.5%	212,8 k €	+3564%	5,8 k €	+115%	2,7 k €	-8.4%	3 k €	-27.6%	4,1 k €	-30.2%	5,8 k €	-77.1%	25,5 k €	+350%	5,7 k €	-12.4%	6,5 k €	-72.4%	23,5 k €	-30.5%	33,8 k €	-86.7%	253,3 k €	-62.1%	668,1 k €	+17.7%	567,9 k €	+521%	91,5 k €	-6.2%	97,5 k €	-6.5%	104,3 k €
Debts	929,8 k €	+5.1%	884,6 k €	+30.0%	680,3 k €	-8.4%	742,4 k €	-12.8%	851,1 k €	+2.9%	827,2 k €	-72.3%	3 M €	+142%	1,2 M €	+31.6%	937,7 k €	-6.6%	1 M €	-2.2%	1 M €	-10.7%	1,1 M €	-18.1%	1,4 M €	+10.9%	1,3 M €	+49.3%	847,9 k €	+7.4%	789,5 k €	+30.7%	603,9 k €	-27.4%	831,3 k €	+26.0%	660 k €	+4.7%	630,5 k €
Other
Workforce	–		–		–		–		–		0,5 ETP	0.0%	0,5 ETP	0.0%	0,5 ETP		–		–		0,5 ETP	0.0%	0,5 ETP	0.0%	0,5 ETP	-44.4%	0,9 ETP	-10.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

GSK INVESTMENT COMPANY

Director · 0883.242.111

Represented by Dries Peeters

Active

Ended mandates

Gerard Schouten

Mandate

Ended

Gerard Schouten

Manager

Ended

GSK INVESTMENT COMPANY

Mandate · 0883.242.111

Ended

GSK INVESTMENT COMPANY

Manager · 0883.242.111

Represented by Gerard Schouten

Ended

At this address

Other companies at this address

Company	CBE no.
BOUWID● Active	0833.021.152
BRIC architectuur● Active	1014.907.040
GSK INVESTMENT COMPANY● Active	0883.242.111
GSK-PROJECTEN● Active	0890.187.608
TERRA NOVA● Active	1035.421.748

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/06/2026	07/07/2025	17/06/2024	16/08/2023	07/07/2022	07/07/2021
General meeting	12/06/2026	13/06/2025	14/06/2024	09/06/2023	10/06/2022	11/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	12/06/2026	25/06/2026	Dutch	PDF
Abridged model	31/12/2024	13/06/2025	07/07/2025	Dutch	PDF
Abridged model	31/12/2023	14/06/2024	17/06/2024	Dutch	PDF
Abridged model	31/12/2022	09/06/2023	16/08/2023	Dutch	PDF
Abridged model	31/12/2021	10/06/2022	07/07/2022	Dutch	PDF
Abridged model	31/12/2020	11/06/2021	07/07/2021	Dutch	PDF
Abridged model	31/12/2019	12/06/2020	12/07/2020	Dutch	PDF
Abridged model	31/12/2018	14/06/2019	08/07/2019	Dutch	PDF
Abridged model	31/12/2017	08/06/2018	27/06/2018	Dutch	PDF
Abridged model	31/12/2016	09/06/2017	24/06/2017	Dutch	PDF
Abridged model	31/12/2015	10/06/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	12/06/2015	29/06/2015	Dutch	PDF
Abridged model	31/12/2013	13/06/2014	26/06/2014	Dutch	PDF
Abridged model	31/12/2012	14/06/2013	17/06/2013	Dutch	PDF
Abridged model	31/12/2011	08/06/2012	29/06/2012	Dutch	PDF
Abridged model	31/12/2010	10/06/2011	15/06/2011	Dutch	PDF
Abridged model	30/06/2010	10/12/2010	01/03/2011	Dutch	PDF
Abridged model	31/12/2008	12/06/2009	22/06/2009	Dutch	PDF
Abridged model	31/12/2007	13/06/2008	04/07/2008	Dutch	PDF
Abridged model	31/12/2006	08/06/2007	12/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

GSK INVESTMENT COMPANY

Director · 0883.242.111

Represented by Dries Peeters

Active

Ended mandates

Gerard Schouten

Mandate

Ended

Gerard Schouten

Manager

Ended

GSK INVESTMENT COMPANY

Mandate · 0883.242.111

Ended

GSK INVESTMENT COMPANY

Manager · 0883.242.111

Represented by Gerard Schouten

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates06/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/03/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/01/2021
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates23/09/2019
ONTSLAGEN - BENOEMINGEN
PDF
Registered office19/02/2016
MAATSCHAPPELIJKE ZETEL
PDF
Mandates15/07/2014
ONTSLAGEN - BENOEMINGEN
PDF
Registered office13/12/2012
MAATSCHAPPELIJKE ZETEL
PDF
Mandates18/02/2011
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025104,2 k €↑
2024
Annual accounts 2024-376,4 €↑
2023
Annual accounts 2023-13,9 k €↑
2022
Annual accounts 2022-36,6 k €↓
2021
Annual accounts 202129 k €↓
2020
Annual accounts 202032,2 k €↑
2019
Annual accounts 201931,9 k €↑
2018
Annual accounts 20189,7 k €↓
2017
Annual accounts 201714,3 k €↓
2016
Annual accounts 2016124,6 k €↑
2015
Annual accounts 201541,6 k €↑
2014
Annual accounts 201437,1 k €↓
2013
Annual accounts 2013176,4 k €↑
2012
Annual accounts 20121,8 k €↓
2011
Annual accounts 201169,7 k €↑
2010
Annual accounts 201018,5 k €↓
2010
Annual accounts 20101,9 M €↑
2008
Annual accounts 2008694,4 k €↑
2007
Annual accounts 2007212,7 k €↑
2006
Annual accounts 2006175,6 k €
07/02/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GSK-Beheer

Overview

What does GSK-Beheer do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline